Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Nautilus Biotechnology, Inc./ 10-K

Annual Report · 10-K

Nautilus Biotechnology, Inc.

NAUTNASDAQEQUITYCurrent

Annual Report

Filed Feb 28, 2024Accepted Feb 28, 2024, 7:04 AM ESTCIK 1808805Accession 0001808805-24-000005
View company →Permanent SEC source ↗
Share

Company context

Current securities

NAUTNASDAQ · EQUITY · Current
Historical securities (1)
ARYANASDAQ · EQUITY · Historical · closed Jun 9, 2021

Recent company filings

  1. EFFECT filingSep 18, 2026
  2. 424B5 filingSep 18, 2026
  3. SCHEDULE 13D/A filingSep 11, 2026
  4. Entry into a Material Definitive Agreement · Termination of a Material Definitive AgreementSep 11, 2026
  5. S-3 filingSep 11, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗